Lana Medical Company Cash Flow Statement

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	11.22	12.46	-1.93	5.49	6.59
Depreciation & Amortization	2.11	3.48	1.96	1.53	1.08
Other Amortization	0.03	0.03	0.01	-	-
Loss (Gain) From Sale of Assets	-0.01	-0.01	0.07	-	-0.01
Loss (Gain) on Equity Investments	-5.37	-5.37	-	-	-
Provision & Write-off of Bad Debts	0.38	1.12	7.97	1.79	-
Other Operating Activities	-15.67	0.89	1.59	0.69	1.29
Change in Accounts Receivable	-11.82	-18.92	-8.52	-2.18	-10.23
Change in Inventory	0.49	-1.19	-0.77	-0.02	0.7
Change in Accounts Payable	5.95	6.7	2.59	-0.04	0.4
Change in Other Net Operating Assets	3.58	1.21	-1.95	-1.66	-4.78
Operating Cash Flow	-9.11	0.39	1.02	5.6	-4.95
Operating Cash Flow Growth	-	-61.60%	-81.70%	-	-
Capital Expenditures	-2.67	-4.12	-3.45	-5.1	-7.22
Sale of Property, Plant & Equipment	0.01	0.01	0.13	-	0.01
Cash Acquisitions	-3.1	-6.97	-	-	-
Sale (Purchase) of Intangibles	-	-	-0.21	-	-
Investment in Securities	-3.59	-3.59	-	-	-
Other Investing Activities	-1.1	-	-	-	0.11
Investing Cash Flow	-10.44	-14.66	-3.53	-5.1	-7.1
Long-Term Debt Issued	-	5	2.89	1.77	0.51
Long-Term Debt Repaid	-	-2.66	-2.11	-2.34	-1.52
Net Debt Issued (Repaid)	3.58	2.34	0.78	-0.57	-1.02
Issuance of Common Stock	-	-	17.52	-	13
Other Financing Activities	9.85	-0.48	-0.34	-0.14	-
Financing Cash Flow	13.43	1.86	17.96	-0.71	11.98
Net Cash Flow	-6.13	-12.4	15.45	-0.21	-0.06
Free Cash Flow	-11.78	-3.73	-2.43	0.5	-12.17
Free Cash Flow Margin	-12.00%	-4.43%	-5.00%	1.22%	-38.06%
Free Cash Flow Per Share	-0.22	-0.07	-0.05	0.01	-0.37
Levered Free Cash Flow	-	-6.37	15.53	-1.11	-
Unlevered Free Cash Flow	-	-6.07	15.74	-0.98	-
Change in Working Capital	-1.8	-12.2	-8.65	-3.9	-13.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.